Probability of cancer treatment and death, stratified by stage and age
| Age group | Cancer treatment | Death | ||
| Odds ratio# (95% CI) | p-value | Hazard ratio¶ (95% CI) | p-value | |
| Stage 1 and 2 lung cancer at diagnosis | ||||
| <60 years | ref | ref | ||
| 60–69 years | 1.25 (0.29–5.44) | 0.769 | 0.84 (0.50–1.40) | 0.497 |
| 70–79 years | 1.61 (0.37–6.95) | 0.522 | 0.97 (0.59–1.58) | 0.887 |
| >80 years | 0.54 (0.12–2.41) | 0.423 | 1.29 (0.75–2.21) | 0.354 |
| Stage 3 and 4 lung cancer at diagnosis | ||||
| <60 years | ref | ref | ||
| 60–69 years | 0.61 (0.38–0.97) | 0.036 | 1.12 (0.97–1.29) | 0.119 |
| 70–79 years | 0.46 (0.29–0.73) | 0.001 | 1.05 (0.91–1.22) | 0.485 |
| >80 years | 0.24 (0.15–0.38) | <0.001 | 1.28 (1.08–1.51) | 0.005 |
Ref: reference group. #: After adjusting for sex, performance status, number of comorbidities and histology; ¶: after adjusting for sex, ethnicity, performance status, number of comorbidities, comorbid cancer and histology. Bold indicates significance.